Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reeh

Showing results (401-410 of 449) with videos related to

Pageof 45
Sort By:
Clinical Genetics|February 27, 2016
Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagusT Ghadban, J T Miro, F Trump, et al.
Annals of Surgical Oncology|March 8, 2012
Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancerFaik G Uzunoglu, Caroline Kaufmann, Harriet Wikman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 19, 2021
Multicenter Experience in Robot-Assisted Minimally Invasive Esophagectomy - a Comparison of Hybrid and Totally Robot-Assisted TechniquesPeter P Grimminger, Julia I Staubitz, Daniel Perez, et al.
Physiological Reports|March 27, 2022
The formalin test does not probe inflammatory pain but excitotoxicity in rodent skinTal Hoffmann, Florian Klemm, Tatjana I Kichko, et al.
Lung Cancer (Amsterdam, Netherlands)|April 4, 2013
C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLCFaik Güntac Uzunoglu, Neda Yavari, Benjamin Alexander Bohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2013
VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinomaF G Uzunoglu, J Kolbe, H Wikman, et al.
Plos One|December 16, 2014
Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancerFaik G Uzunoglu, Ebba Dethlefsen, Annkathrin Hanssen, et al.
Journal of Clinical Medicine|February 24, 2024
Risk Factor Analysis for Developing Major Complications Following Esophageal Surgery-A Two-Center StudyBjörn-Ole Stüben, Gabriel Andreas Plitzko, Louisa Stern, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 14, 2014
A new paradigm to understand and treat diabetic neuropathyA Hidmark, T Fleming, S Vittas, et al.
American Journal of Physiology. Renal Physiology|October 5, 2020
Afferent renal innervation in anti-Thy1.1 nephritis in ratsKristina Rodionova, Roland Veelken, Karl F Hilgers, et al.
Pageof 45

Showing results (401-410 of 449) with videos related to

Sort By:
Pageof 45
Clinical Genetics|February 27, 2016
Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the oesophagusT Ghadban, J T Miro, F Trump, et al.
Annals of Surgical Oncology|March 8, 2012
Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancerFaik G Uzunoglu, Caroline Kaufmann, Harriet Wikman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 19, 2021
Multicenter Experience in Robot-Assisted Minimally Invasive Esophagectomy - a Comparison of Hybrid and Totally Robot-Assisted TechniquesPeter P Grimminger, Julia I Staubitz, Daniel Perez, et al.
Physiological Reports|March 27, 2022
The formalin test does not probe inflammatory pain but excitotoxicity in rodent skinTal Hoffmann, Florian Klemm, Tatjana I Kichko, et al.
Lung Cancer (Amsterdam, Netherlands)|April 4, 2013
C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLCFaik Güntac Uzunoglu, Neda Yavari, Benjamin Alexander Bohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2013
VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinomaF G Uzunoglu, J Kolbe, H Wikman, et al.
Plos One|December 16, 2014
Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancerFaik G Uzunoglu, Ebba Dethlefsen, Annkathrin Hanssen, et al.
Journal of Clinical Medicine|February 24, 2024
Risk Factor Analysis for Developing Major Complications Following Esophageal Surgery-A Two-Center StudyBjörn-Ole Stüben, Gabriel Andreas Plitzko, Louisa Stern, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 14, 2014
A new paradigm to understand and treat diabetic neuropathyA Hidmark, T Fleming, S Vittas, et al.
American Journal of Physiology. Renal Physiology|October 5, 2020
Afferent renal innervation in anti-Thy1.1 nephritis in ratsKristina Rodionova, Roland Veelken, Karl F Hilgers, et al.
Pageof 45